Insider Transactions in Q4 2024 at Bei Gene, Ltd. (BGNE)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 14
2024
|
John Oyler Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,300,000
+30.38%
|
$0
$0.5 P/Share
|
|
Dec 10
2024
|
Xiaodong Wang Director |
SELL
Open market or private sale
|
Direct |
41,760
-41.7%
|
$7,892,640
$189.29 P/Share
|
|
Dec 10
2024
|
Xiaodong Wang Director |
BUY
Exercise of conversion of derivative security
|
Direct |
41,760
+50.0%
|
$250,560
$6.5 P/Share
|
|
Dec 09
2024
|
Baker Bros. Advisors LP |
SELL
Open market or private sale
|
Indirect |
1,037,017
-4.92%
|
$204,292,349
$197.25 P/Share
|
|
Dec 06
2024
|
Xiaobin Wu President, COO & GM China |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
Dec 02
2024
|
Hhlr Advisors, Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
17,842,500
-12.49%
|
$3,568,500,000
$200.0 P/Share
|
|
Nov 26
2024
|
Xiaodong Wang Director |
SELL
Open market or private sale
|
Indirect |
7,883
-40.87%
|
$1,489,887
$189.62 P/Share
|
|
Nov 26
2024
|
Xiaodong Wang Director |
SELL
Open market or private sale
|
Direct |
40,468
-21.29%
|
$7,648,452
$189.69 P/Share
|
|
Nov 26
2024
|
Xiaodong Wang Director |
BUY
Exercise of conversion of derivative security
|
Direct |
38,461
+48.73%
|
$230,766
$6.5 P/Share
|
|
Oct 08
2024
|
John Oyler Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-35.4%
|
$2,320,000
$232.77 P/Share
|
|
Oct 08
2024
|
John Oyler Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
6,175
-35.41%
|
$1,432,600
$232.77 P/Share
|